Medtronic Derivative Asset (Liability), Fair Value, Gross Asset (Liability) increased by 27.4% to $149.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 83.5%, from $901.00M to $149.00M. Over 5 years (FY 2020 to FY 2025), Derivative Asset (Liability), Fair Value, Gross Asset (Liability) shows an upward trend with a 0.5% CAGR.
other_derivative_asset_liability_fair_value_gross_asset__617a8a| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$194.00M | -$21.00M | $91.00M | $149.00M | $566.00M | $845.00M | $1.03B | $74.00M | $132.00M | $115.00M | $638.00M | $439.00M | $593.00M | $569.00M | $479.00M | $901.00M | -$84.00M | -$188.00M | $117.00M | $149.00M |
| QoQ Change | — | +89.2% | +533.3% | +63.7% | +279.9% | +49.3% | +22.0% | -92.8% | +78.4% | -12.9% | +454.8% | -31.2% | +35.1% | -4.0% | -15.8% | +88.1% | -109.3% | -123.8% | +162.2% | +27.4% |
| YoY Change | — | — | — | — | +391.8% | >999% | >999% | -50.3% | -76.7% | -86.4% | -38.1% | +493.2% | +349.2% | +394.8% | -24.9% | +105.2% | -114.2% | -133.0% | -75.6% | -83.5% |